Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year […]
United States Johnf Crowley Bradleyl Campbell Amicus Therapeutics Amicus Therapeutics Inc China Universal Asset Management Co
Source: themarketsdaily.com